| BMY Bristol-Myers Squibb Co. | 31.53% | 685,182 | $38.8M | Reduce -0.1% |
| BDSX Biodesix Inc. | 7.14% | 5,736,113 | $8.8M | Add +0.7% |
| ACAD Acadia Pharmaceuticals Inc. | 5.05% | 338,400 | $6.2M | Reduce -15.5% |
| ELUT Elutia Inc. | 3.73% | 1,225,489 | $4.6M | Reduce -7.3% |
| PRTA Prothena Corp. PLC | 3.43% | 304,574 | $4.2M | Add +45.3% |
| NBIX Neurocrine Biosciences Inc. | 3.36% | 30,240 | $4.1M | No change |
| CORT Corcept Therapeutics Inc. | 3.03% | 74,000 | $3.7M | No change |
| UTHR United Therapeutics Corp. | 2.87% | 10,000 | $3.5M | No change |
| AXGN Axogen Inc. | 2.64% | 197,000 | $3.2M | No change |
| DCGO Docgo Inc. | 2.64% | 764,062 | $3.2M | Add +48.4% |
| QDEL Quidelortho Corp. | 2.45% | 67,619 | $3.0M | No change |
| PHR Phreesia Inc. | 2.35% | 114,700 | $2.9M | No change |
| TVTX Travere Therapeutics Inc. | 2.10% | 148,000 | $2.6M | No change |
| MASI Masimo Corp. | 2.06% | 15,280 | $2.5M | No change |
| HROW Harrow Inc. | 1.99% | 72,910 | $2.4M | No change |
| STOK Stoke Therapeutics Inc. | 1.88% | 210,000 | $2.3M | No change |
| OVV Ovintiv Inc. | 1.72% | 52,200 | $2.1M | No change |
| CSTL Castle Biosciences Inc. | 1.69% | 78,000 | $2.1M | Add +34.5% |
| PTGX Protagonist Therapeutics Inc. | 1.51% | 48,000 | $1.9M | No change |
| EQT Eqt Corp. | 1.30% | 34,619 | $1.6M | No change |
| FHTX Foghorn Therapeutics Inc. | 1.19% | 310,930 | $1.5M | Reduce -3.1% |
| ALKS Alkermes PLC | 1.17% | 50,000 | $1.4M | No change |
| TMCI Treace Medical Concepts Inc. | 0.98% | 161,350 | $1.2M | Add +136.1% |
| NVCR Novocure Ltd. | 0.75% | 31,000 | $924K | Add +55.0% |
| TXG 10X Genomics Inc. Class A | 0.58% | 50,000 | $718K | Add +66.7% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.55% | 16,000 | $673K | New |
| XNCR Xencor Inc. | 0.49% | 26,000 | $597K | Add +111.4% |
| KNSA Kiniksa Pharmaceuticals Ltd. | 0.48% | 30,000 | $593K | No change |
| KALV Kalvista Pharmaceuticals Inc. | 0.46% | 67,000 | $567K | Reduce -18.3% |
| ATEC Alphatec Holdings Inc. | 0.43% | 58,000 | $532K | Reduce -70.7% |
| CADL Candel Therapeutics Inc. | 0.42% | 60,000 | $521K | New |
| WVE Wave Life Sciences Ltd. | 0.40% | 40,000 | $495K | No change |
| INBX Inhibrx Biosciences Inc. | 0.40% | 32,110 | $494K | No change |
| HALO Halozyme Therapeutics Inc. | 0.39% | 10,000 | $478K | No change |
| CYTK Cytokinetics Inc. | 0.38% | 10,000 | $470K | No change |
| APLS Apellis Pharmaceuticals Inc. | 0.36% | 14,000 | $447K | No change |
| SRPT Sarepta Therapeutics Inc. | 0.35% | 3,500 | $426K | Add +40.0% |
| OM Outset Medical Inc. | 0.33% | 368,766 | $409K | Add +3587.7% |
| XENE Xenon Pharmaceuticals Inc. | 0.32% | 10,000 | $392K | No change |
| ACCELERATE DIAGNOSTICS INC | 0.32% | 325,239 | $390K | No change |
| TELA Tela Bio Inc. | 0.31% | 125,000 | $378K | New |
| SWTX Springworks Therapeutics Inc. | 0.29% | 10,000 | $361K | No change |
| QURE Uniqure NV | 0.29% | 20,000 | $353K | No change |
| LUNG Pulmonx Corp. | 0.28% | 51,000 | $346K | New |
| SRRK Scholar Rock Holding Corp. | 0.28% | 8,000 | $346K | New |
| AXSM Axsome Therapeutics Inc. | 0.28% | 4,000 | $338K | No change |
| BCRX Biocryst Pharmaceuticals Inc. | 0.24% | 40,000 | $301K | No change |
| ATRA Atara Biotherapeutics Inc. | 0.24% | 22,000 | $293K | New |
| ARVN Arvinas Inc. | 0.23% | 15,000 | $288K | No change |
| KPTI Karyopharm Therapeutics Inc. | 0.23% | 419,832 | $284K | Reduce -10.6% |
| BIOHAVEN PHARMACEUTICAL HOLD | 0.22% | 7,365 | $275K | No change |
| FOLD Amicus Therapeutics Inc. | 0.21% | 28,000 | $264K | No change |
| CGEM Cullinan Therapeutics Inc. | 0.20% | 20,000 | $244K | No change |
| KROS Keros Therapeutics Inc. | 0.19% | 15,000 | $237K | Add +114.3% |
| BPMC Blueprint Medicines Corp. | 0.19% | 2,700 | $235K | No change |
| MLTX Moonlake Immunotherapeutics | 0.18% | 4,000 | $217K | New |
| ZBIO Zenas Biopharma Inc. | 0.11% | 16,500 | $135K | New |
| TECL Dire Dai Tec Bull 3X ETF-Usd | 0.10% | 18,000 | $128K | New |
| GOSS Gossamer Bio Inc. | 0.10% | 138,176 | $125K | No change |
| IFRX Inflarx NV | 0.10% | 50,000 | $124K | No change |
| LQDA Liquidia Corp. | 0.10% | 10,000 | $118K | No change |
| CHRS Coherus Oncology Inc. | 0.09% | 82,000 | $113K | Reduce -78.0% |
| NPCE Neuropace Inc. | 0.09% | 10,000 | $112K | New |
| ALMS Alumis Inc. | 0.06% | 10,000 | $79K | No change |
| VTYX Ventyx Biosciences Inc. | 0.05% | 28,800 | $63K | No change |
| ZNTL Zentalis Pharmaceuticals Inc. | 0.04% | 17,000 | $52K | Add +6.3% |
| TSVT 2SEVENTY Bio Inc. | 0.04% | 15,833 | $47K | No change |
| CERO THERAPEUTICS HLDGS INC | 0.00% | 12,972 | $778 | No change |